title: Management of Crohn's disease in poor responders to adalimumab.
abstract: Anti-tumor necrosis factor therapy with adalimumab is an effective therapy for the induction and maintenance of remission in moderate to severe Crohn's disease. Although a large proportion of patients show a favorable clinical response to adalimumab, therapy failure is common. In this review, we provide a practical overview of adalimumab therapy in patients with Crohn's disease, with a specific focus on the clinical management of adalimumab failure. In the case of inadequate efficacy, a thorough assessment is required to confirm inflammatory disease activity and rule out noninflammatory causes. Evaluation may include biomarkers (fecal calprotectin and serum C-reactive protein), colonoscopy, and/or magnetic resonance enterography/enteroclysis. Furthermore, adalimumab trough levels and antibodies to adalimumab are informational after the confirmation of active inflammation. In the case of low or undetectable adalimumab trough levels, dose escalation to 40 mg weekly is recommended, whereas high antibody titers or adverse events frequently require switching to an alternative anti-TNF agent such as infliximab. Active inflammation despite therapeutic adalimumab trough levels requires alternative strategies such as switching to drugs with a different mode of action or surgical intervention.
authors.affiliation: Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Nanne Kh
authors.initials: NKh
authors.lastname: de Boer
authors.affiliation: Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.
authors.forename: Mark
authors.initials: M
authors.lastname: Löwenberg
authors.affiliation: Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
authors.forename: Frank
authors.initials: F
authors.lastname: Hoentjen
keywords: anti-TNF; biological; inflammatory bowel disease; infliximab; loss of response
references.citation: Arthritis Rheum. 2007 May;56(5):1417-23
references.pmid: 17469098
references.citation: Gastroenterology. 2007 Jan;132(1):52-65
references.pmid: 17241859
references.citation: Am J Gastroenterol. 2011 Apr;106(4):674-84
references.pmid: 21407178
references.citation: Inflamm Bowel Dis. 2013 May;19(6):1112-22
references.pmid: 23584130
references.citation: Gut. 2014 Feb;63(2):292-9
references.pmid: 23525574
references.citation: J Crohns Colitis. 2014 Feb;8(2):120-8
references.pmid: 23932783
references.citation: Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24
references.pmid: 18799360
references.citation: Ann Intern Med. 2007 Jun 19;146(12):829-38
references.pmid: 17470824
references.citation: Gastroenterology. 2009 Nov;137(5):1628-40
references.pmid: 19664627
references.citation: Am J Gastroenterol. 2010 May;105(5):1133-9
references.pmid: 20145610
references.citation: Inflamm Bowel Dis. 2011 Jan;17(1):141-51
references.pmid: 20848500
references.citation: Aliment Pharmacol Ther. 2011 Oct;34(8):911-22
references.pmid: 21883326
references.citation: Gut. 2008 Nov;57(11):1518-23
references.pmid: 18566104
references.citation: Aliment Pharmacol Ther. 2008 Nov 1;28(9):1122-6
references.pmid: 18691349
references.citation: Inflamm Bowel Dis. 2013 Jun;19(7):1528-33
references.pmid: 23518810
references.citation: N Engl J Med. 2010 Apr 15;362(15):1383-95
references.pmid: 20393175
references.citation: Aliment Pharmacol Ther. 2010 Jan;31(1):92-101
references.pmid: 19709098
references.citation: Gastroenterology. 1995 Jul;109(1):129-35
references.pmid: 7797011
references.citation: J Crohns Colitis. 2010 Oct;4(4):367-76
references.pmid: 21122531
references.citation: Autoimmun Rev. 2014 Jan;13(1):24-30
references.pmid: 23792214
references.citation: N Engl J Med. 2007 Jul 19;357(3):239-50
references.pmid: 17634459
references.citation: Ann Rheum Dis. 2015 Mar;74(3):513-8
references.pmid: 24326008
references.citation: Am J Gastroenterol. 2011 Feb;106(2):199-212; quiz 213
references.pmid: 21045814
references.citation: Inflamm Bowel Dis. 2014 Feb;20(2):251-8
references.pmid: 24378599
references.citation: Therap Adv Gastroenterol. 2009 Jul;2(4):245-51
references.pmid: 21180547
references.citation: BioDrugs. 2013 Jun;27(3):247-62
references.pmid: 23580096
references.citation: N Engl J Med. 2003 Feb 13;348(7):601-8
references.pmid: 12584368
references.citation: Clin Gastroenterol Hepatol. 2014 Jan;12(1):80-84.e2
references.pmid: 23891927
references.citation: Inflamm Bowel Dis. 2012 Oct;18(10):1894-9
references.pmid: 22238138
references.citation: N Engl J Med. 2013 Aug 22;369(8):711-21
references.pmid: 23964933
references.citation: J Crohns Colitis. 2010 Oct;4(4):355-66
references.pmid: 21122530
references.citation: Gut. 2009 Jul;58(7):940-8
references.pmid: 19201775
references.citation: N Engl J Med. 2005 Sep 15;353(11):1114-23
references.pmid: 16162882
references.citation: World J Gastroenterol. 2012 Oct 7;18(37):5219-24
references.pmid: 23066316
references.citation: Gastroenterology. 2006 Feb;130(2):323-33; quiz 591
references.pmid: 16472588
references.citation: N Engl J Med. 2005 Nov 3;353(18):1912-25
references.pmid: 16267322
references.citation: Lancet. 2002 May 4;359(9317):1541-9
references.pmid: 12047962
references.citation: Am J Gastroenterol. 2011 Apr;106(4):685-98
references.pmid: 21427713
references.citation: Aliment Pharmacol Ther. 2012 Dec;36(11-12):1040-8
references.pmid: 23061650
references.citation: J Crohns Colitis. 2013 Mar;7(2):154-60
references.pmid: 22537637
references.citation: N Engl J Med. 2012 Oct 18;367(16):1519-28
references.pmid: 23075178
references.citation: Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15
references.pmid: 18081730
references.citation: Gastroenterology. 2012 Jan;142(1):63-70.e5; quiz e31
references.pmid: 21945953
references.citation: Inflamm Bowel Dis. 2012 Nov;18(11):2011-7
references.pmid: 22223566
references.citation: Gut. 2007 Sep;56(9):1232-9
references.pmid: 17299059
references.citation: Clin Rheumatol. 2013 Oct;32(10):1429-35
references.pmid: 23887439
references.citation: Aliment Pharmacol Ther. 2012 Sep;36(5):459-66
references.pmid: 22784296
references.citation: Gastroenterology. 2007 Aug;133(2):412-22
references.pmid: 17681162
references.citation: Clin Gastroenterol Hepatol. 2012 Sep;10(9):1002-7; quiz e78
references.pmid: 22343692